|
1
|
Lavoie JR and Rosu-Myles M: Uncovering the
secretes of mesenchymal stem cells. Biochimie. 95:2212–2221. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Konala VB, Mamidi MK, Bhonde R, Das AK,
Pochampally R and Pal R: The current landscape of the mesenchymal
stromal cell secretome: A new paradigm for cell-free regeneration.
Cytotherapy. 18:13–24. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li TS, Takahashi M, Ohshima M, Qin SL,
Kubo M, Muramatsu K and Hamano K: Myocardial repair achieved by the
intramyocardial implantation of adult cardiomyocytes in combination
with bone marrow cells. Cell Transplant. 17:695–703. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel G, Krause P, Wöhrle S, Nowak P,
Ayturan M, Kluba T, Brehm BR, Neumeister B, Köhler D, Rosenberger
P, et al: Bone marrow-derived human mesenchymal stem cells express
cardiomyogenic proteins but do not exhibit functional
cardiomyogenic differentiation potential. Stem Cells Dev.
21:2457–2470. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bi B, Schmitt R, Israilova M, Nishio H and
Cantley LG: Stromal cells protect against acute tubular injury via
an endocrine effect. J Am Soc Nephrol. 18:2486–2496. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cantinieaux D, Quertainmont R, Blacher S,
Rossi L, Wanet T, Noël A, Brook G, Schoenen J and Franzen R:
Conditioned medium from bone marrow-derived mesenchymal stem cells
improves recovery after spinal cord injury in rats: An original
strategy to avoid cell transplantation. PLoS One. 8:e695152013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Janjanin S, Djouad F, Shanti RM, Baksh D,
Gollapudi K, Prgomet D, Rackwitz L, Joshi AS and Tuan RS: Human
palatine tonsil: A new potential tissue source of multipotent
mesenchymal progenitor cells. Arthritis Res Ther. 10:R832008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ryu KH, Cho KA, Park HS, Kim JY, Woo SY,
Jo I, Choi YH, Park YM, Jung SC, Chung SM, et al: Tonsil-derived
mesenchymal stromal cells: Evaluation of biologic, immunologic and
genetic factors for successful banking. Cytotherapy. 14:1193–1202.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ryu KH, Kim SY, Kim YR, Woo SY, Sung SH,
Kim HS, Jung SC, Jo I and Park JW: Tonsil-derived mesenchymal stem
cells alleviate concanavalin A-induced acute liver injury. Exp Cell
Res. 326:143–154. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park M, Kim YH, Woo SY, Lee HJ, Yu Y, Kim
HS, Park YS, Jo I, Park JW, Jung SC, et al: Tonsil-derived
mesenchymal stem cells ameliorate CCl4-induced liver fibrosis in
mice via autophagy activation. Sci Rep. 5:86162015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim SY, Kim YR, Park WJ, Kim HS, Jung SC,
Woo SY, Jo I, Ryu KH and Park JW: Characterisation of
insulin-producing cells differentiated from tonsil derived
mesenchymal stem cells. Differentiation. 90:27–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park YS, Kim HS, Jin YM, Yu Y, Kim HY,
Park HS, Jung SC, Han KH, Park YJ, Ryu KH and Jo I: Differentiated
tonsil-derived mesenchymal stem cells embedded in Matrigel restore
parathyroid cell functions in rats with parathyroidectomy.
Biomaterials. 65:140–152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park S, Choi Y, Jung N, Yu Y, Ryu KH, Kim
HS, Jo I, Choi BO and Jung SC: Myogenic differentiation potential
of human tonsil-derived mesenchymal stem cells and their potential
for use to promote skeletal muscle regeneration. Int J Mol Med.
37:1209–1220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim YH, Park M, Cho KA, Kim BK, Ryu JH,
Woo SY and Ryu KH: Tonsil-derived mesenchymal stem cells promote
bone mineralization and reduce marrow and visceral adiposity in a
mouse model of senile osteoporosis. Stem Cells Dev. 25:1161–1171.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ryu JH, Park M, Kim BK, Ryu KH and Woo SY:
Tonsil-derived mesenchymal stromal cells produce CXCR2-binding
chemokines and acquire follicular dendritic cell-like phenotypes
under TLR3 stimulation. Cytokine. 73:225–235. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park M, Kim YH, Ryu JH, Woo SY and Ryu KH:
Immune suppressive effects of tonsil-derived mesenchymal stem cells
on mouse bone-marrow-derived dendritic cells. Stem Cells Int.
2015:1065402015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cho KA, Lee JK, Kim YH, Park M, Woo SY and
Ryu KH: Mesenchymal stem cells ameliorate B-cell-mediated immune
responses and increase IL-10-expressing regulatory B cells in an
EBI3-dependent manner. Cell Mol Immunol. Jan 2–2017.(Epub ahead of
print). View Article : Google Scholar :
|
|
18
|
Kim JY, Park M, Kim YH, Ryu KH, Lee KH,
Cho KA and Woo SY: Tonsil-derived mesenchymal stem cells (T-MSCs)
prevent Th17-mediated autoimmune response via regulation of the
programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway.
J Tissue Eng Regen Med. Jan 20–2017.(Epub ahead of print).
View Article : Google Scholar
|
|
19
|
Whitehead JP, Richards AA, Hickman IJ,
Macdonald GA and Prins JB: Adiponectin-a key adipokine in the
metabolic syndrome. Diabetes Obes Metab. 8:264–280. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu M and Liu F: Regulation of adiponectin
multimerization, signaling and function. Best Pract Res Clin
Endocrinol Metab. 28:25–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang ZV and Scherer PE: Adiponectin, the
past two decades. J Mol Cell Biol. 8:93–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cnop M, Havel PJ, Utzschneider KM, Carr
DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD and Kahn
SE: Relationship of adiponectin to body fat distribution, insulin
sensitivity and plasma lipoproteins: Evidence for independent roles
of age and sex. Diabetologia. 46:459–469. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Furler SM, Gan SK, Poynten AM, Chisholm
DJ, Campbell LV and Kriketos AD: Relationship of adiponectin with
insulin sensitivity in humans, independent of lipid availability.
Obesity (Silver Spring). 14:228–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu Y, Park YS, Kim HS, Kim HY, Jin YM,
Jung SC, Ryu KH and Jo I: Characterization of long-term in vitro
culture-related alterations of human tonsil-derived mesenchymal
stem cells: Role for CCN1 in replicative senescence-associated
increase in osteogenic differentiation. J Anat. 225:510–518. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Niimi K, Takahashi E and Itakura C:
Adiposity-related biochemical phenotype in senescence-accelerated
mouse prone 6 (SAMP6). Comp Med. 59:431–436. 2009.PubMed/NCBI
|
|
27
|
Furukawa S, Fujita T, Shimabukuro M, Iwaki
M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M and
Shimomura I: Increased oxidative stress in obesity and its impact
on metabolic syndrome. J Clin Invest. 114:1752–1761. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo H, Ling W, Wang Q, Liu C, Hu Y and Xia
M: Cyanidin 3-glucoside protects 3T3-L1 adipocytes against H2O2- or
TNF-alpha-induced insulin resistance by inhibiting c-Jun
NH2-terminal kinase activation. Biochem Pharmacol. 75:1393–1401.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gustafson B, Hammarstedt A, Hedjazifar S
and Smith U: Restricted adipogenesis in hypertrophic obesity: The
role of WISP2, WNT, and BMP4. Diabetes. 62:2997–3004. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Choi SS, Kim ES, Jung JE, Marciano DP, Jo
A, Koo JY, Choi SY, Yang YR, Jang HJ, Kim EK, et al: PPARγ
antagonist Gleevec improves insulin sensitivity and promotes the
browning of white adipose tissue. Diabetes. 65:829–839. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Matsubara M, Maruoka S and Katayose S:
Inverse relationship between plasma adiponectin and leptin
concentrations in normal-weight and obese women. Eur J Endocrinol.
147:173–180. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Asayama K, Hayashibe H, Dobashi K, Uchida
N, Nakane T, Kodera K, Shirahata A and Taniyama M: Decrease in
serum adiponectin level due to obesity and visceral fat
accumulation in children. Obes Res. 11:1072–1079. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fujita K, Nishizawa H, Funahashi T,
Shimomura I and Shimabukuro M: Systemic oxidative stress is
associated with visceral fat accumulation and the metabolic
syndrome. Circ J. 70:1437–1442. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gradinaru D, Margina D, Borsa C, Ionescu
C, Ilie M, Costache M, Dinischiotu A and Prada GI: Adiponectin:
Possible link between metabolic stress and oxidative stress in the
elderly. Aging Clin Exp Res. Sep 29–2016.(Epub ahead of print).
PubMed/NCBI
|
